Diabetes mellitus and risk of new‐onset and recurrent heart failure: a systematic review and meta‐analysis

S Kodama, K Fujihara, C Horikawa, T Sato… - ESC Heart …, 2020 - Wiley Online Library
Despite mounting evidence of the positive relationship between diabetes mellitus (DM) and
heart failure (HF), the entire context of the magnitude of risk for HF in relation to DM remains …

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation …

GYH Lip, C Laroche, PM Ioachim… - European heart …, 2014 - academic.oup.com
Abstract Background The EURObservational Research Programme-Atrial Fibrillation
General Registry Pilot Phase (EORP-AF Pilot) provides systematic collection of …

Outcomes of early rhythm control therapy in patients with atrial fibrillation and a high comorbidity burden in large real-world cohorts

J Dickow, S Kany, V Roth Cardoso… - Circulation …, 2023 - Am Heart Assoc
Background: A recent subanalysis of the EAST-AFNET 4 (Early Treatment of Atrial
Fibrillation for Stroke Prevention Trial) suggests a stronger benefit of early rhythm control …

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation

V Jacobs, HT May, TL Bair, BG Crandall, M Cutler… - Heart Rhythm, 2015 - Elsevier
Background Risk stratification tools are needed to select the right candidates for catheter
ablation of atrial fibrillation (AF). Both the CHADS 2 and CHA 2 DS 2-VAS c scores have …

Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: a systematic review and meta-analysis of cohort studies

X Zhou, K Cao, S Kou, QU Shencheng, H Li… - International Journal of …, 2017 - Elsevier
Objective To evaluate the role of CHADS 2 score on predicting ischaemic stroke or transient
ischaemic attack (TIA) and death in patients with coronary artery disease (CAD), irrespective …

CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation

A Sonaglioni, C Lonati, E Rigamonti, M Vigano… - Aging Clinical and …, 2022 - Springer
Background During the last decade, the CHA2DS2-VASc score has been associated with
adverse clinical outcomes in several cardiovascular (CV) and non-cardiovascular diseases …

CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome

Z Rozenbaum, A Elis, M Shuvy, D Vorobeichik… - European Journal of …, 2016 - Elsevier
Abstract Background The CHA2DS2-VASc score has been recommended for the
assessment of thromboembolic risk in patients with atrial fibrillation. Hypothesis The …

Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality

FZ Ahmed, C Sammut-Powell, CS Kwok, T Tay… - EP …, 2022 - academic.oup.com
Aims To determine if remotely monitored physiological data from cardiac implantable
electronic devices (CIEDs) can be used to identify patients at high risk of mortality. Methods …

Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on …

D Capodanno, R Rossini, G Musumeci… - International journal of …, 2015 - Elsevier
Abstract Background The CHA 2 DS 2-VASc and HAS-BLED are well-validated stroke risk
prediction scores for atrial fibrillation (AF), but their role in risk stratification of major adverse …

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation

D Morrone, S Kroep, F Ricci, G Renda, G Patti… - Journal of clinical …, 2020 - mdpi.com
Background and Objectives: Atrial fibrillation (AF) is associated with increased mortality,
predictors of which are poorly characterized. We investigated the predictive power of the …